secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2026-10-01T20:05:32+00:00
Accession:  0001104659-26-112826
Event type: debt
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 2.04
LLM model:  deepseek-v4.1-flash:cloud@v2

TransCode pays Yorkville $840,975 and obtains waiver after stock falls below $1.72 Floor Price
--------------------------------------------------------------------------------

- On October 1, 2026, TransCode and Yorkville executed a waiver; TransCode made a $840,975 prepayment including $759,000 principal, $75,900 premium, and $6,075 accrued interest.
- The daily VWAP of TransCode common stock was below the $1.72 Floor Price for 10 of 14 trading days from September 11, 2026 to September 30, 2026, triggering an Amortization Event.
- Yorkville waived Amortization Events deemed to occur on or before September 30, 2026 and through October 31, 2026; remaining Convertible Note principal is about $4.1 million.
- Under the Convertible Notes, an Amortization Event requires monthly payments of 18% of outstanding principal plus 10% of principal paid and accrued interest until repayment or cure.
- The SEPA with YA II PN, Ltd. allows TransCode to sell up to $14 million of common stock; Yorkville also agreed to advance up to $6.0 million via convertible notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465926112826/0001104659-26-112826-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465926112826/tm2626839d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-112826

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer